Brief: Cumberland Pharmaceuticals Says Co Received Notice Of Approval From FDA For Application Associated With Next Generation Caldolor Injection Product
28/01/2019 22:36
Jan 28 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS - ON JAN 25, CO RECEIVED NOTICE
OF
APPROVAL FROM FDA FOR APPLICATION ASSOCIATED WITH NEXT
GENERATION CALDOLOR INJECTION PRODUCT
Source text: (https://bit.ly/2sRyt8T)
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM